Chinese patients to get cheaper cancer drugs from Sep

The drugs are all crucial in dealing with haematological neoplasms and solid tumours, and have great clinical value and huge benefits for patients, the National Healthcare Security Administration said.

It asked pharmaceutical companies to adhere to the price cut in line with the lowered procurement prices of these drugs, Xinhua news agency reported.

A range of several more drugs have been selected to be included in the medical insurance reimbursement list later.

Image courtesy of thesatimes |

Share this post